Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

MLN8054

Cat. No.: 0225LY-0665
Appearance: Solid
Purity: ≥98%
Identity: Confirmed by NMR, and HPLC.
Size:
MLN8054
Add to basket

Product Overview

Description: MLN8054 serves as a selective and powerful Aurora A kinase inhibitor, demonstrating an IC50 of 4 nM.
Synonym: 869363-13-3; 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid; 4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzoic acid; 4-(9-chloro-7-(2,6-difluorophenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)benzoic acid; Benzoic acid, 4-((9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-; 4-((9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)benzoic acid
CAS No.: 869363-13-3
Compound CID: 11712649
Formula: C25H15ClF2N4O2
Formula Weight: 476.86

Specification

Targets&IC50: Aurora A: 4 nM
Relative Density: 1.48 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: MLN8054 can be used in mitotic research to explore the selective inhibition of the Aurora A kinase.

Library Information

Target: PKA; Src; Casein kinase; Aurora kinase
Receptor: Aurora A; Aurora B; CK2; Lck; PKA
Pathways: Metabolism; Tyrosine kinase/adaptors; Cell cycle/Checkpoint; Angiogenesis; Chromatin/Epigenetic; Stem cell regulation
Plate Number: AOCL-9
Plate Location: f2
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 31.25 mg/mL; 65.53 mM
Water Max Solubility: <1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility: <1 mg/mL (insoluble or slightly soluble)
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.